Q4 EPS Estimates for Henry Schein Decreased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Barrington Research decreased their Q4 2025 earnings per share estimates for shares of Henry Schein in a report issued on Tuesday, May 6th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.29 for the quarter, down from their previous estimate of $1.34. Barrington Research has a “Outperform” rating and a $86.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.25 EPS, Q3 2026 earnings at $1.35 EPS, Q4 2026 earnings at $1.44 EPS, FY2026 earnings at $5.20 EPS and FY2027 earnings at $5.60 EPS.

A number of other brokerages also recently issued reports on HSIC. Wells Fargo & Company reduced their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday. StockNews.com lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Finally, Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $79.30.

Henry Schein Stock Performance

HSIC stock opened at $68.89 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.44 billion, a PE ratio of 28.35, a P/E/G ratio of 2.13 and a beta of 0.87. The business has a 50 day moving average of $67.62 and a 200-day moving average of $71.46. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.10 earnings per share.

Insider Buying and Selling

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is owned by insiders.

Institutional Trading of Henry Schein

Hedge funds and other institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc grew its position in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Investment Management Corp VA ADV bought a new position in Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. bought a new stake in shares of Henry Schein during the 1st quarter valued at about $34,000. Venturi Wealth Management LLC grew its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares in the last quarter. Finally, Quent Capital LLC increased its position in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.